Molecular surveillance of antimicrobial resistance and transmission pattern of <i>Mycobacterium leprae</i> in Chinese leprosy patients
Santosh Chokkakula(Chungbuk National University), Hongsheng Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Yanfei Kuang(Hunan Provincial Center for Disease Control and Prevention), Ying Shi(Chinese Academy of Medical Sciences & Peking Union Medical College), Naveenchandra Suryadevara(Vanderbilt University), Limei Shen(Guizhou Provincial Science and Technology Department), De Wang(Guizhou Provincial Science and Technology Department), Tiejun Shui(Yunnan Province Science and Technology Department), Haiqin Jiang(Nanjing University), Zhiming Chen(Chinese Academy of Medical Sciences & Peking Union Medical College), Ziyi Chen(Chinese Academy of Medical Sciences & Peking Union Medical College), Jun He(Yunnan Province Science and Technology Department), Yanqing Chen(Chinese Academy of Medical Sciences & Peking Union Medical College), Jie Liu(Guizhou Provincial Science and Technology Department), Weida Liu(Chinese Academy of Medical Sciences & Peking Union Medical College), Wenyue Zhang(Chinese Academy of Medical Sciences & Peking Union Medical College), Liangbin Yan(Chinese Academy of Medical Sciences & Peking Union Medical College), Jun Yang(Yunnan Province Science and Technology Department), Hao Wang(Chinese PLA General Hospital), Wei Gao(Chinese Academy of Medical Sciences & Peking Union Medical College), Li Xiong(Yunnan Province Science and Technology Department), Jinlan Li(Fujian Medical University), Meiwen Yu(Chinese Academy of Medical Sciences & Peking Union Medical College), Huan Chen(Hunan Provincial Center for Disease Control and Prevention), Varalakshmi Vissa(Chinese Academy of Medical Sciences & Peking Union Medical College)
Cited by 22
Related Papers
Prevalence, Incidence, and Lifetime Risk of Atrial Fibrillation in China
|CHEST Journal|2014|270
Combination therapy with nirmatrelvir and molnupiravir improves the survival of SARS-CoV-2 infected mice
|Antiviral Research|2022|82
Influenza Treatment: Limitations of Antiviral Therapy and Advantages of Drug Combination Therapy
|Microorganisms|2023|77
SARS-CoV-2 drug resistance and therapeutic approaches
|Heliyon|2025|44
IFI44L as a Forward Regulator Enhancing Host Antituberculosis Responses
|Journal of Immunology Research|2021|35